UBC’s global access strategy featured on CBC Radio
Last month, CBC Radio’s’ The Link featured a piece on UBC’s new strategy for global access to its technologies, developed in collaboration with UAEM, and the most promising current technology for which global access will be important. It includes an interview with Dr. Kishor Wasan, who is working on an improved formulation of Amphotericin B, a toxic and difficult-to-use drug used to combat fungal infections in cancer and AIDS patients, as well as leishmaniasis, a potentially lethal tropical disease that infects half a million every year. Listen to the piece.
Advertisement
